Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanzhou Foci Pharmaceutical is a historic Chinese pharmaceutical enterprise primarily focused on the research, development, and manufacturing of Traditional Chinese Medicine (TCM). Established in 1929, the company is famous for inventing the concentrated pill (Nongsuo Wan) technology, which modernized TCM by providing standardized and convenient dosages. Its international commerce division, Lanzhou Foci International Commerce, facilitates the global export of over 400 types of TCM products to more than 28 countries and regions, including the United States, Japan, and Southeast Asia. The company is a state-controlled entity listed on the Shenzhen Stock Exchange and maintains high-standard GMP manufacturing facilities in Lanzhou. Lanzhou Foci remains a pivotal player in the internationalization of traditional herbal therapies through its extensive distribution network and modernized production processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lanzhou Foci International Commerce.